| http://www.w3.org/ns/prov#value | - a and methicillin-resistant Staphylococcus aureus (MRSA), avoidance of unnecessary overuse and adverse effects of systemic antibiotics, including bacterial resistance Risks, harms, costs: Additional expense of topical otic antibiotics compared with oral antibiotics, potential difficulties in drug delivery to the middle ear if presence of obstructing debris or purulence in the ear canal Benefit-har
|
